REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION DURING APLASIA IN PRIMARY HIGH-RISK AND RELAPSED ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Stoelzel, F. [1 ]
Schetelig, J. [1 ]
Platzbecker, U. [1 ]
Thiede, C. [1 ]
Illmer, T. [1 ]
Schaich, M. [1 ]
Fuessel, M. [2 ]
Theuser, C. [1 ]
Haenel, M. [3 ]
Mahlberg, R. [4 ]
Ehninger, G. [1 ]
Bornhaeuser, M. [1 ]
机构：
[1] Med Klin 1, Dresden, Germany
[2] DKMS, Dresden, Germany
[3] Klinikum Chemnitz, Chemnitz, Germany
[4] Krankenanstalt Borromaerinnen Trier, Trier, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0716
引用
下载
收藏
页码：291 / 291
页数：1
相关论文
共 50 条
  • [41] Allogeneic stem cell transplantation with reduced-intensity conditioning in patients with relapsed lymphoma
    Rivas, M.
    Berro, M.
    Belaustegui, S.
    Prates, V.
    Yantorno, S.
    Milone, J.
    Remaggi, G.
    Rolon, J. Martinez
    Milone, G.
    Basquiera, A.
    Garcia, J.
    Sturich, G.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S257 - S258
  • [42] Clofarabine/Ara-C treatment combined with reduced-intensity conditioning for allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute leukaemia
    Buchholz, S.
    Krauter, J.
    Dammann, E.
    Ehrlich, S.
    Port, M.
    Weissinger, E.
    Stadler, M.
    Eder, M.
    Ganser, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S207 - S207
  • [43] Cytoreduction with clofarabine/Ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute leukaemia
    Buchholz, S.
    Krauter, J.
    Dammann, E.
    Beutel, G.
    Stadler, M.
    Eder, M.
    Ganser, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S281 - S282
  • [44] Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan
    Oran, Betul
    Giralt, Sergio
    Saliba, Rima
    Hosing, Chitra
    Popat, Uday
    Khouri, Issa
    Couriel, Daniel
    Qazilbash, Muzaffar
    Anderlini, Paolo
    Kebriaei, Partow
    Ghosh, Shubhra
    Carrasco-Yalan, Antonio
    de Meis, Ernesto
    Anagnostopoulos, Athanasios
    Donato, Michele
    Champlin, Richard E.
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (04) : 454 - 462
  • [45] Outcome of allogeneic stem cell transplantation in adults with high-risk myeloid malignancies using an alemtuzemab based reduced-intensity-conditioning regimen
    Tauro, S
    Craddock, C
    Peggs, K
    Begum, G
    Chopra, R
    Littlewood, T
    Parker, A
    Marsh, J
    Cook, G
    Hale, G
    Snowden, J
    Milligan, D
    Hunter, A
    Russell, N
    Goldstone, A
    Mahendra, P
    Linch, D
    Mackinnon, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 3 - 3
  • [46] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)
    Popat, U
    Heslop, HE
    Durett, A
    May, R
    Krance, RA
    Brenner, MK
    Carrum, G
    BONE MARROW TRANSPLANTATION, 2006, 37 (06) : 547 - 552
  • [47] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)
    U Popat
    H E Heslop
    A Durett
    R May
    R A Krance
    M K Brenner
    G Carrum
    Bone Marrow Transplantation, 2006, 37 : 547 - 552
  • [48] Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia
    U Platzbecker
    C Thiede
    M Füssel
    G Geissler
    T Illmer
    B Mohr
    M Hänel
    R Mahlberg
    U Krümpelmann
    F Weissinger
    M Schaich
    C Theuser
    G Ehninger
    M Bornhäuser
    Leukemia, 2006, 20 : 707 - 714
  • [49] Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia
    Platzbecker, U
    Thiede, C
    Fuessel, M
    Geissler, G
    Illmer, T
    Mohr, B
    Hänel, M
    Mahlberg, R
    Krümpelmann, U
    Weissinger, F
    Schaich, M
    Theuser, C
    Ehninger, G
    Bornhäuser, M
    LEUKEMIA, 2006, 20 (04) : 707 - 714
  • [50] Flamsa Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation for High Risk Acute Myeloid Leukemia Patients
    Michallet, Mauricette
    Sobh, Mohamad
    Detrait, Marie Y.
    Labussiere-Wallet, Helene
    Hayette, Sandrine
    Tigaud, Isabelle
    Elhamri, Mohamed
    Gilis, Lila
    Lebras, Laure L.
    Barraco, Fiorenza
    Ducastelle, Sophie
    Bozzoli, Valentina
    Nicolini, Franck E.
    Thomas, Xavier
    BLOOD, 2014, 124 (21)
12345